Table 1

SIR and 95% CIs for cancer among patients with a hospital-based diagnosis of a venous ulcer, Denmark, 1982-2012

Follow-up timeAll cancersHematological cancersNonhematological cancers
Overall 1.11 (1.07-1.14) 1.30 (1.15-1.47) 1.09 (1.06-1.13) 
<90 d 2.07 (1.82-2.34) 3.50 (2.26-5.16) 1.98 (1.73-2.25) 
90 d to <1 y 1.16 (1.05-1.28) 1.24 (0.80-1.83) 1.15 (1.04-1.27) 
1 to <4 y 1.12 (1.06-1.19) 1.32 (1.06-1.64) 1.11 (1.05-1.18) 
4 to <7 y 1.05 (0.97-1.12) 1.22 (0.91-1.60) 1.03 (0.96-1.11) 
7 to <10 y 1.02 (0.93-1.12) 1.03 (0.68-1.49) 1.02 (0.93-1.12) 
≥10 y 1.01 (0.94-1.09) 1.18 (0.87-1.56) 1.00 (0.93-1.08) 
Follow-up timeAll cancersHematological cancersNonhematological cancers
Overall 1.11 (1.07-1.14) 1.30 (1.15-1.47) 1.09 (1.06-1.13) 
<90 d 2.07 (1.82-2.34) 3.50 (2.26-5.16) 1.98 (1.73-2.25) 
90 d to <1 y 1.16 (1.05-1.28) 1.24 (0.80-1.83) 1.15 (1.04-1.27) 
1 to <4 y 1.12 (1.06-1.19) 1.32 (1.06-1.64) 1.11 (1.05-1.18) 
4 to <7 y 1.05 (0.97-1.12) 1.22 (0.91-1.60) 1.03 (0.96-1.11) 
7 to <10 y 1.02 (0.93-1.12) 1.03 (0.68-1.49) 1.02 (0.93-1.12) 
≥10 y 1.01 (0.94-1.09) 1.18 (0.87-1.56) 1.00 (0.93-1.08) 

SIRs computed according to Danish national cancer incidence rates according to 5-year age groups, sex, and 5-year intervals of year of diagnosis. CIs were derived using Byar approximation, assuming that the observed number of cases in a specific category follows a Poisson distribution. We used exact 95% CIs when the observed number of cancers was <10.

Close Modal

or Create an Account

Close Modal
Close Modal